NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in NextCure, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −8 vs. Q4 2024
- Shares held
- 15.4M
- −669.8K (−4.2%) vs. Q4 2024
- Total value
- $7.38M
- −$5.75M (−43.8%) vs. Q4 2024
- New holders
- 0
- 10 more added
- Sold out
- 8
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 262 | $126 | 0.00% | +10+4.0% | Added |
| BNP Paribas Arbitrage, SA | 385 | $185 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 807 | $387 | 0.00% | +2+0.2% | Added |
| Tower Research Capital LLC (TRC) | 1,869 | $898 | 0.00% | +1,211+184.0% | Added |
| UBS Group AG | 8,537 | $4.10K | 0.00% | +4,335+103.2% | Added |
| Dimensional Fund Advisors LP | 12,175 | $5.85K | 0.00% | −73,678−85.8% | Reduced |
| Millennium Management LLC | 12,272 | $5.89K | 0.00% | −30,245−71.1% | Reduced |
| HSBC Holdings PLC | 17,257 | $8.45K | 0.00% | −106−0.6% | Reduced |
| XTX Topco Ltd | 18,028 | $8.66K | 0.00% | +4,451+32.8% | Added |
| Schonfeld Strategic Advisors LLC | 18,935 | $9.09K | 0.00% | −2,865−13.1% | Reduced |
| Engineers Gate Manager LP | 20,198 | $9.70K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 25,000 | $12.0K | 0.01% | 00.0% | Unchanged |
| Ieq Capital, LLC | 37,342 | $17.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 47,493 | $22.8K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 51,700 | $24.8K | 0.00% | −15,900−23.5% | Reduced |
| State Street Corp | 65,392 | $31.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 67,518 | $32.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 90,643 | $43.5K | 0.00% | +11,965+15.2% | Added |
| Armistice Capital, LLC | 104,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 120,012 | $57.6K | 0.01% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 130,000 | $62.4K | 0.02% | 00.0% | Unchanged |
| Macquarie Group Ltd | 150,000 | $72.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 236,185 | $113.5K | 0.00% | +2,271+1.0% | Added |
| Cardiff Park Advisors, LLC | 262,000 | $125.8K | 0.01% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 265,442 | $127.5K | 0.14% | −138,256−34.2% | Reduced |
| BML Capital Management, LLC | 273,536 | $131.4K | 0.11% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 315,180 | $151.3K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 404,144 | $194.1K | 0.01% | −295,856−42.3% | Reduced |
| Renaissance Technologies LLC | 479,962 | $230.5K | 0.00% | −39,338−7.6% | Reduced |
| Acadian Asset Management LLC | 488,440 | $233.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 556,686 | $267.4K | 0.00% | −170,893−23.5% | Reduced |
| Cable Car Capital LLC | 670,101 | $321.9K | 0.37% | +54,223+8.8% | Added |
| Vanguard Group Inc | 987,324 | $473.9K | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,141,200 | $548.1K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 1,419,370 | $681.7K | 0.00% | +30,330+2.2% | Added |
| Pfizer Inc | 1,891,763 | $908.6K | 0.18% | +433,213+29.7% | Added |
| Affinity Asset Advisors, LLC | 2,302,598 | $1.11M | 0.17% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,671,856 | $1.28M | 0.10% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 0 | $0 | 0.00% | −185,936−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −107,672−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −58,259−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −48,186−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,951−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,191−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |